This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Impact of COVID-19 on primary retinal detachments

Impact of COVID-19 on primary retinal detachments
Reviewed by Sofia Rokerya

3 October 2022 | Sofia Rokerya | EYE - Vitreo-Retinal, EYE - General | Coronavirus disease 19, Primary retinal detachment, Vitrectomy
Share This

This study aimed to describe the impact of the COVID-19 pandemic on the presentation characteristics, timings, and surgical decisions for primary rhegmatogenous retinal detachment (RRD). The cohort included all patients who presented to a Portuguese centre over a two-year period, and these were divided into two groups: pre-COVID and COVID group. The onset of the COVID-19 pandemic was recorded as starting on March 18 2020, the same day the first pandemic-related lockdown came into effect in Portugal. This study enrolled 449 eyes of 443 patients: 272 in the pre-COVID group and 177 in the COVID one. Of the patients, 63.6% were male. The mean ± SD age was 63.0 ±13.2 years (range 13-92 years). The majority of eyes (59.0%, n = 259) were phakic. Further, 55.5% (n = 151) of eyes presented with macular detachment in the pre-COVID group compared with 67% (n = 118) in the COVID group (odds ratio [OR] 1.62; 95% confidence interval [CI]: 1.09-3.86; p = 0.016). Sub analysis of macular status according to age 50 years as the cut off, showed that in the control year, no differences were found. However, there was a higher incidence of macular detachment in older patients, in the COVID era (OR 0.43, 95% CI: 0.19-1.00, p = 0.050). The time from symptom onset to hospital presentation was longer in the COVID era (p = 0.021). Also, the time from hospital presentation to surgery was longer during the pandemic year (p < 0.001). A sub analysis of the patients that were not submitted to surgery on the presentation day (n = 263) revealed a higher waiting time until surgery in the COVID year (median [IQR]: two [1-3] versus three [2-4.5] days, p < 0.001. In the COVID period, silicone oil (OR 2.03, 95% CI: 1.09-3.79, p = 0.025) and C3F8 gas (OR 2.42, 95% CI: 1.57-3.71, p < 0.001) were used more often, which can be taken as surrogate of the increased severity of the cases during the pandemic. No differences in anatomical success or final visual acuity were found between the two groups at three months follow-up. Limitations: retrospective nature; PVR, an important aspect of the RRD disease spectrum and was not assessed; short follow-up.

The impact of COVID-19 pandemic on surgical primary retinal detachments.
Ferreira A, Afonso M, Silva N, Meirelles A.
OPHTHALMOLOGICA
2022;245(2):111-6.
Share This
Sofia Rokerya
CONTRIBUTOR
Sofia Rokerya

MBBS MRCOphth FRCSI, King's College University Hospital, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency